Drug Trial Radar · NCT02822144
General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke
Last checked: Nov 20, 2026Latest source record: May 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
351
Actual
Start
Sep 29, 2016
Primary completion
Aug 2020
Study completion Aug 2020
Sponsor
- Lead sponsor
- Rennes University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 4, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In France, the annual incidence rate of acute ischaemic stroke is around 150 000 patients, 65 % of whom keep long-term disability. Several multicentric randomized controlled trials have shown the benefit of a mechanical thrombectomy in the acute phase of ischaemic stroke on functional disability, compared to a medical treatment alone (thrombolysis). The timeliness of revascularisation is an essential factor of good prognosis. This intra-arterial treatment, associated with thrombolysis if applicable, is the reference treatment of large-vessel occlusion. The stillness of the patient is required to control the safety of the recanalization. Currently, either a general anesthesia or a sedation can be performed. Several studies have shown a trend to superiority of the sedation but none was conducted with a high level of proof methodology. The aim of our multicentric randomized controlled trial is to compare sedation and general anesthesia during intra-arterial thrombectomy for an acute ischaemic stroke in the anterior cerebral circulation. The main outcome will be the efficacy on the functional neurological prognosis at 3 months.
Conditions
- Stroke
Interventions
EtomidateDrug
SuccinylcholineDrug
PropofolDrug
RemifentanilDrug
LidocaineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Score on the modified Rankin scaleTime frame: 3 months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Département d'anesthésie-réanimation - Hôpital de la Cavale Blanche, CHU de Brest
Brest, France
Service d'anesthésie-réanimation - Fondation A. de Rothschild
Paris, France
Fédération d'anesthésie-réanimation - Hôpital Pontchaillou, CHU de Rennes
Rennes, France
Service d'anesthésie-réanimation 1 - Hôpital Bretonneau, CHU de Tours
Tours, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.